MEI Pharma (now rebranded as Lite Strategy) has become the first U.S.-listed company to adopt Litecoin as a primary reserve asset, committing $100 million to the cryptocurrency a...
MEI Pharma (now rebranded as Lite Strategy) has become the first U.S.-listed company to adopt Litecoin as a primary reserve asset, committing $100 million to the cryptocurrency a...